Long-Acting Injectable Antipsychotics for the Maintenance Treatment of Bipolar Disorder

Depot antipsychotics have been used as a strategy to reduce non-adherence to medications in schizophrenia and bipolar disorder (BD). This article reviews the literature on the efficacy and safety of first- and second-generation depot antipsychotics (FGDA and SGDA, respectively) for the maintenance t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS drugs 2012-05, Vol.26 (5), p.403-420
Hauptverfasser:	Gigante, Alexandre Duarte, Lafer, Beny, Yatham, Lakshmi N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult and adolescent clinical studies Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Antipsychotics Biological and medical sciences Bipolar Disorder - drug therapy Bipolar disorders Delayed-Action Preparations Drug Approval Humans Injections Medical sciences Medication Adherence Medicine Medicine & Public Health Mood disorders Neurology Neuropharmacology Neurosciences Pharmacology. Drug treatments Pharmacotherapy Psychiatry Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Review Article Risperidone - administration & dosage Risperidone - adverse effects Risperidone - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!